• Aucun résultat trouvé

Acarbose for type 2 diabetes prevention.

N/A
N/A
Protected

Academic year: 2021

Partager "Acarbose for type 2 diabetes prevention."

Copied!
1
0
0

Texte intégral

Loading

Références

Documents relatifs

The Diabetes Atherosclerosis Intervention Study (DAIS): a study conducted in cooperation with the World Health Organization. Prospective randomised study of intensive insulin

Our results indicate that the frequency of preclini- cal carotid atherosclerosis in patients with adult- onset initially non-insulin requiring autoimmune diabetes, also called LADA,

Cost-effectiveness Model, CDS Cornerstone Diabetes Simulation, EBMI Evidence-Based Medicine Integrator Simulator, ECHO-T2DM Economics and Health Outcomes in Type 2 Diabetes

11 Moreover, Ahmedani et al observed an improvement in the num- ber of acute diabetes complications with active glucose monitoring, alteration of drug dosage and timing, dietary

The Canadian Primary Care Sentinel Surveillance Network, a Pan-Canadian project led by the CFPC that conducts standardized surveillance on selected chronic

Randomized trial of patient-titrated insulin glargine compared with standard oral therapy: lessons for family practice from the Canadian INSIGHT trial.. Shah BR, Hux JE, Laupacis

23 These data, 23 along with a similar study of exenatide versus insulin glargine in patients using metformin and a sulfonyl- urea, 20 suggest that the GLP1

As part of the SLICK project, this study screened Alberta First Nations individuals with diabetes for complications of the disease and surveyed them about their